With 0.72 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.21 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $25.5 whereas the lowest price it dropped to was $19.8013. The 52-week range on RGC shows that it touched its highest point at $83.60 and its lowest point at $0.09 during that stretch. Beta for the stock currently stands at 2.07.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of RGC was up-trending over the past week, with a rise of 18.53%, but this was up by 111.34% over a month. Three-month performance surged to 43.26% while six-month performance rose 37.79%. The stock gained 17961.54% in the past year, while it has gained 17148.02% so far this year.
Float and Shares Shorts:
At present, 494.49 million RGC shares are outstanding with a float of 56.59 million shares on hand for trading. On 2025-12-15, short shares totaled 1.21 million, which was 25.0 higher than short shares on 1763078400. In addition to Mr. Yat-Gai Au as the firm’s Founder, Chairman & CEO, Ms. Michelle Chan serves as its Financial Controller, CFO & Principal Financial Officer.
